Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2396)
All Articles published online
|
Aug 21, 2006 (publication date) through Nov 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ranjbar M, Alizadeh AHM, Hajilooi M, Mousavi SM. Polymorphisms of interleukin-1R receptor antagonist genes in patients with chronic hepatitis B in Iran. World J Gastroenterol 2006; 12(31): 5044-5047 [PMID: 16937503 DOI: 10.3748/wjg.v12.i31.5044] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i31/5044.htm |
| Number | Citing Articles |
| 1 |
Elisabetta Fontanini, Annarosa Cussigh, Carlo Fabris, Edmondo Falleti, Pierluigi Toniutto, Davide Bitetto, Sara Cmet, Elisa Fumolo, Ezio Fornasiere, Sara Bignulin, David J. Pinato, Rosalba Minisini, Mario Pirisi. Gender-related Distribution of the Interleukin-1β and Interleukin-1 Receptor Antagonist Gene Polymorphisms in Patients with End-stage Liver Disease. Inflammation 2010; 33(4): 251 doi: 10.1007/s10753-009-9179-2
|
| 2 |
Avik Biswas, Rajesh Panigrahi, Manisha Pal, Binay K. De, Sekhar Chakrabarti, Mrinmoy K. Ghosh, Bikash C. Chandra Seth, Susanta Roychowdhury, Runu Chakravarty. Association of Interleukin-1β and Gene Polymorphisms with Liver Pathogenesis in Hepatitis B Virus Infection among Eastern Indian Population. Journal of Clinical and Experimental Hepatology 2013; 3(4): 281 doi: 10.1016/j.jceh.2013.11.006
|
| 3 |
Nadia Ghasemian, Majid Shahbazi. Interferon Gamma Gene Polymorphism (+874 T > A) and Chronic Hepatitis B in the Population of Gorgan, North-Eastern Iran. Jundishapur Journal of Microbiology 2016; 9(8) doi: 10.5812/jjm.33639
|
| 4 |
Matthew B Carroll. The impact of biologic response modifiers on hepatitis B virus infection. Expert Opinion on Biological Therapy 2011; 11(4): 533 doi: 10.1517/14712598.2011.554810
|